• Medical
  • Finance
  • Legal
  • Hemp
  • Marketing
  • Global
  • Podcast
  • Join
  • Sign in
Skip to content
Cannabiz

Cannabiz

The Business of Cannabis

  • Medical
  • Finance
  • Legal
  • Hemp
  • Marketing
  • Global
  • Podcast
  • Join
  • Sign in
Home ยป Roby Zomer Cannabis News | Cannabiz

Tag: Roby Zomer Cannabis News | Cannabiz

Company news: Emyria; Cann Group; Creso Pharma; Cronos; MGC Pharma

by Martin Lane April 14, 2022April 14, 2022

Emyria Emyria has begun dosing participants in a Phase 1 clinical trial assessing the safety and […]

Roby Zomer

MGC Pharma signs European distribution deal

by Martin Lane April 6, 2022April 6, 2022
Roby Zomer

Company news: MGC Pharma; Emyria; ECS Botanics; Rua Bioscience; AusCann; Cannasouth; Cronos; Althea

by Martin Lane September 2, 2021February 26, 2022

MGC Pharma bullish on clinical trials program

by Martin Lane May 26, 2021May 26, 2021

MGC Pharma backs up Covid trial data with more positive findings

by Steve Jones May 11, 2021May 11, 2021
Roby Zomer

MGC Pharma to acquire research company MediCaNL

by Martin Lane April 28, 2021April 28, 2021
Oliver Horn - Cannabis News Australia - Cannabiz

Company news: Elixinol Global; Bod Australia; MGC Pharma; Cronos Australia; Epsilon Healthcare

by Martin Lane April 23, 2021April 29, 2021
Roby Zomer

MGC Pharma inks worldwide distribution deal for food supplement

by Martin Lane February 19, 2021February 19, 2021

MGC Pharma expands brain cancer study

by Martin Lane February 16, 2021February 18, 2021
Roby Zomer

MGC Pharma makes London Stock Exchange debut

by Martin Lane February 10, 2021February 10, 2021

Posts navigation

1 2 Older posts

My Account

Sign in

Category

  • Medical
  • Finance
  • Legal
  • Hemp
  • Marketing
  • Global
  • General
  • Podcast

About

  • About/contact us
  • Join
  • Sign in
  • Privacy Policy
  • Website Terms & Conditions
  • Membership Terms & Conditions
  • Submit a Guest Post
  • About cannabis
  • Editorial policy
Cannabiz
  • Facebook
  • Linkedin
  • Instagram
© 2022 Cannabiz.